The combination of tanshinone IIA with cyclophosphamide increases CD4+ T cell, CD4+/CD8+ T cell and NK cell populations compared to single treatment in NSCLC Lewis-bearing mice, so it can improve the immunological function in lung cancer [534]. Here, CD4 is linked to lung carcinoma.